216 related articles for article (PubMed ID: 10993855)
1. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.
Fu Y; Chang WC; Mark D; Califf RM; Mackenzie B; Granger CB; Topol EJ; Hlatky M; Armstrong PW
Circulation; 2000 Sep; 102(12):1375-81. PubMed ID: 10993855
[TBL] [Abstract][Full Text] [Related]
2. Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.
Kaul P; Armstrong PW; Fu Y; Knight JD; Clapp-Channing NE; Sutherland W; Granger CB; Mark DB;
Can J Cardiol; 2004 Jun; 20(8):760-6. PubMed ID: 15229756
[TBL] [Abstract][Full Text] [Related]
3. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
Kaul P; Armstrong PW; Chang WC; Naylor CD; Granger CB; Lee KL; Peterson ED; Califf RM; Topol EJ; Mark DB
Circulation; 2004 Sep; 110(13):1754-60. PubMed ID: 15381645
[TBL] [Abstract][Full Text] [Related]
4. Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.
Chang WC; Fu Y; Ohman EM; Gupta M; Morris A; Roth SN; Granger CB; Califf RM; Topol EJ; Mark DB; Armstrong PW
Can J Cardiol; 2000 Oct; 16(10):1231-9. PubMed ID: 11064297
[TBL] [Abstract][Full Text] [Related]
5. An ischemia-guided approach for risk stratification in patients with acute coronary syndromes.
Pepine CJ
Am J Cardiol; 2000 Dec; 86(12B):27M-35M. PubMed ID: 11206016
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK).
Collinson J; Flather MD; Fox KA; Findlay I; Rodrigues E; Dooley P; Ludman P; Adgey J; Bowker TJ; Mattu R
Eur Heart J; 2000 Sep; 21(17):1450-7. PubMed ID: 10952837
[TBL] [Abstract][Full Text] [Related]
7. Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry).
Anderson HV; Gibson RS; Stone PH; Cannon CP; Aguirre F; Thompson B; Knatterud GL; Braunwald E
Am J Cardiol; 1997 Jun; 79(11):1441-6. PubMed ID: 9185630
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
[TBL] [Abstract][Full Text] [Related]
9. Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update.
Cohen M
Drugs; 2002; 62(12):1755-70. PubMed ID: 12149045
[TBL] [Abstract][Full Text] [Related]
10. Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction.
Popma JJ; Suk J
Am J Cardiol; 2001 Oct; 88(8A):25K-29K. PubMed ID: 11694216
[TBL] [Abstract][Full Text] [Related]
11. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.
Yusuf S
Am J Cardiol; 1999 Sep; 84(5A):20M-25M. PubMed ID: 10505539
[TBL] [Abstract][Full Text] [Related]
12. Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes.
Khadour FH; Fu Y; Chang WC; Ma X; Mark D; Granger CB; Topol EJ; Califf RM; Armstrong PW;
Can J Cardiol; 2003 Mar; 19(3):257-63. PubMed ID: 12677281
[TBL] [Abstract][Full Text] [Related]
13. Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction.
Bosch X; Marrugat J
Cochrane Database Syst Rev; 2001; (4):CD002130. PubMed ID: 11687143
[TBL] [Abstract][Full Text] [Related]
14. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
[TBL] [Abstract][Full Text] [Related]
15. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Metz BK; White HD; Granger CB; Simes RJ; Armstrong PW; Hirsh J; Fuster V; MacAulay CM; Califf RM; Topol EJ
J Am Coll Cardiol; 1998 Jun; 31(7):1493-8. PubMed ID: 9626825
[TBL] [Abstract][Full Text] [Related]
17. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators.
Armstrong PW; Fu Y; Chang WC; Topol EJ; Granger CB; Betriu A; Van de Werf F; Lee KL; Califf RM
Circulation; 1998 Nov; 98(18):1860-8. PubMed ID: 9799205
[TBL] [Abstract][Full Text] [Related]
18. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators.
Yusuf S; Flather M; Pogue J; Hunt D; Varigos J; Piegas L; Avezum A; Anderson J; Keltai M; Budaj A; Fox K; Ceremuzynski L
Lancet; 1998 Aug; 352(9127):507-14. PubMed ID: 9716054
[TBL] [Abstract][Full Text] [Related]
19. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Hudson MP; Granger CB; Topol EJ; Pieper KS; Armstrong PW; Barbash GI; Guerci AD; Vahanian A; Califf RM; Ohman EM
Circulation; 2001 Sep; 104(11):1229-35. PubMed ID: 11551872
[TBL] [Abstract][Full Text] [Related]
20. An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial.
Cho L; Bhatt DL; Marso SP; Brennan D; Holmes DR; Califf RM; Topol EJ
Am J Med; 2003 Feb; 114(2):106-11. PubMed ID: 12586229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
